Novel 5′ Fusion Partners of ETV1 and ETV4 in Prostate Cancer
Gene fusions involving the erythroblast transformation-specific (ETS) transcription factors ERG, ETV1, ETV4, ETV5, and FLI1 are a common feature of prostate carcinomas (PCas). Themost common upstream fusion partner described is the androgenregulated prostate-specific gene TMPRSS2, most frequently wi...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2013-07-01
|
| Series: | Neoplasia: An International Journal for Oncology Research |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558613800668 |
| _version_ | 1828530518750134272 |
|---|---|
| author | Joao D. Barros-Silva Paula Paulo Anne Cathrine Bakken Nuno Cerveira Marthe Løvf Rui Henrique Carmen Jerönimo Ragnhild A. Lothe Rolf Inge Skotheim Manuel R. Teixeira |
| author_facet | Joao D. Barros-Silva Paula Paulo Anne Cathrine Bakken Nuno Cerveira Marthe Løvf Rui Henrique Carmen Jerönimo Ragnhild A. Lothe Rolf Inge Skotheim Manuel R. Teixeira |
| author_sort | Joao D. Barros-Silva |
| collection | DOAJ |
| description | Gene fusions involving the erythroblast transformation-specific (ETS) transcription factors ERG, ETV1, ETV4, ETV5, and FLI1 are a common feature of prostate carcinomas (PCas). Themost common upstream fusion partner described is the androgenregulated prostate-specific gene TMPRSS2, most frequently with ERG, but additional 5′fusion partners have been described. We performed 5′ rapid amplification of cDNA ends in 18 PCas with ETV1, ETV4, or ETV5 outlier expression to identify the 5′ fusion partners. We also evaluated the exon-level expression profile of these ETS genes in 14 cases. We identified and confirmed by fluorescent in situ hybridization (FISH) and reverse transcription-polymerase chain reaction the two novel chimeric genes OR51E2-ETV1 and UBTF-ETV4 in two PCas. OR51E2 encodes a G-protein.coupled receptor that is overexpressed in PCas, whereas UBTF is a ubiquitously expressed gene encoding an HMG-box DNA-binding protein involved in ribosome biogenesis. We additionally describe two novel gene fusion combinations of previously described genes, namely, SLC45A3- ETV4 and HERVK17-ETV4. Finally, we found one PCa with TMPRSS2-ETV1, one with C15orf21-ETV1, one with EST14-ETV1, and two with 14q133-q21.1-ETV1. In nine PCas (eight ETV1 and one ETV5), exhibiting ETS outlier expression and genomic rearrangement detected by FISH, no 5′ fusion partner was found. Our findings contribute significantly to characterize the heterogeneous group of ETS gene fusions and indicate that all genes described as 5′ fusion partners with one ETS gene can most likely be rearranged with any of the other ETS genes involved in prostate carcinogenesis. |
| first_indexed | 2024-12-11T22:24:24Z |
| format | Article |
| id | doaj.art-9078565292754abf9399e868a3bc34d7 |
| institution | Directory Open Access Journal |
| issn | 1476-5586 1522-8002 |
| language | English |
| last_indexed | 2024-12-11T22:24:24Z |
| publishDate | 2013-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Neoplasia: An International Journal for Oncology Research |
| spelling | doaj.art-9078565292754abf9399e868a3bc34d72022-12-22T00:48:20ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022013-07-0115772072610.1593/neo.13232Novel 5′ Fusion Partners of ETV1 and ETV4 in Prostate CancerJoao D. Barros-Silva0Paula Paulo1Anne Cathrine Bakken2Nuno Cerveira3Marthe Løvf4Rui Henrique5Carmen Jerönimo6Ragnhild A. Lothe7Rolf Inge Skotheim8Manuel R. Teixeira9Department of Genetics, Portuguese Oncology Institute, Porto, PortugalDepartment of Genetics, Portuguese Oncology Institute, Porto, PortugalDepartment of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, NorwayDepartment of Genetics, Portuguese Oncology Institute, Porto, PortugalDepartment of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, NorwayDepartment of Pathology, Portuguese Oncology Institute, Porto, PortugalDepartment of Genetics, Portuguese Oncology Institute, Porto, PortugalDepartment of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, NorwayDepartment of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, NorwayDepartment of Genetics, Portuguese Oncology Institute, Porto, PortugalGene fusions involving the erythroblast transformation-specific (ETS) transcription factors ERG, ETV1, ETV4, ETV5, and FLI1 are a common feature of prostate carcinomas (PCas). Themost common upstream fusion partner described is the androgenregulated prostate-specific gene TMPRSS2, most frequently with ERG, but additional 5′fusion partners have been described. We performed 5′ rapid amplification of cDNA ends in 18 PCas with ETV1, ETV4, or ETV5 outlier expression to identify the 5′ fusion partners. We also evaluated the exon-level expression profile of these ETS genes in 14 cases. We identified and confirmed by fluorescent in situ hybridization (FISH) and reverse transcription-polymerase chain reaction the two novel chimeric genes OR51E2-ETV1 and UBTF-ETV4 in two PCas. OR51E2 encodes a G-protein.coupled receptor that is overexpressed in PCas, whereas UBTF is a ubiquitously expressed gene encoding an HMG-box DNA-binding protein involved in ribosome biogenesis. We additionally describe two novel gene fusion combinations of previously described genes, namely, SLC45A3- ETV4 and HERVK17-ETV4. Finally, we found one PCa with TMPRSS2-ETV1, one with C15orf21-ETV1, one with EST14-ETV1, and two with 14q133-q21.1-ETV1. In nine PCas (eight ETV1 and one ETV5), exhibiting ETS outlier expression and genomic rearrangement detected by FISH, no 5′ fusion partner was found. Our findings contribute significantly to characterize the heterogeneous group of ETS gene fusions and indicate that all genes described as 5′ fusion partners with one ETS gene can most likely be rearranged with any of the other ETS genes involved in prostate carcinogenesis.http://www.sciencedirect.com/science/article/pii/S1476558613800668 |
| spellingShingle | Joao D. Barros-Silva Paula Paulo Anne Cathrine Bakken Nuno Cerveira Marthe Løvf Rui Henrique Carmen Jerönimo Ragnhild A. Lothe Rolf Inge Skotheim Manuel R. Teixeira Novel 5′ Fusion Partners of ETV1 and ETV4 in Prostate Cancer Neoplasia: An International Journal for Oncology Research |
| title | Novel 5′ Fusion Partners of ETV1 and ETV4 in Prostate Cancer |
| title_full | Novel 5′ Fusion Partners of ETV1 and ETV4 in Prostate Cancer |
| title_fullStr | Novel 5′ Fusion Partners of ETV1 and ETV4 in Prostate Cancer |
| title_full_unstemmed | Novel 5′ Fusion Partners of ETV1 and ETV4 in Prostate Cancer |
| title_short | Novel 5′ Fusion Partners of ETV1 and ETV4 in Prostate Cancer |
| title_sort | novel 5 fusion partners of etv1 and etv4 in prostate cancer |
| url | http://www.sciencedirect.com/science/article/pii/S1476558613800668 |
| work_keys_str_mv | AT joaodbarrossilva novel5fusionpartnersofetv1andetv4inprostatecancer AT paulapaulo novel5fusionpartnersofetv1andetv4inprostatecancer AT annecathrinebakken novel5fusionpartnersofetv1andetv4inprostatecancer AT nunocerveira novel5fusionpartnersofetv1andetv4inprostatecancer AT martheløvf novel5fusionpartnersofetv1andetv4inprostatecancer AT ruihenrique novel5fusionpartnersofetv1andetv4inprostatecancer AT carmenjeronimo novel5fusionpartnersofetv1andetv4inprostatecancer AT ragnhildalothe novel5fusionpartnersofetv1andetv4inprostatecancer AT rolfingeskotheim novel5fusionpartnersofetv1andetv4inprostatecancer AT manuelrteixeira novel5fusionpartnersofetv1andetv4inprostatecancer |